| (AUD) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 5.25M | 31.25% |
| Operating expense | — | — |
| Net income | -4.79M | -65.36% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RAC.AX returned +78.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -23.1% |
| 1 year | +78.7% |
| 5 years | -31.4% |
| 10 years | +876.7% |
| All-time high | $3.70 (Feb 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RAC.AX would be worth today ›No. Racura Oncology Ltd has not paid a dividend in the past 12 months.
Racura Oncology Ltd is part of the Healthcare sector.
Racura Oncology Ltd has a market cap of 411.74M AUD, based on the latest quote.
